Goldman Sachs Raises Price Target for Novo Nordisk to 436 Danish Kroner (352), Reiterates Buy - BN

marketscreener
2026.01.22 05:40

Goldman Sachs raises its price target for Novo Nordisk to 436 Danish kroner (previously 352), and reiterates its buy recommendation - BN